IMMUNOQURE AG has a total of 42 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PFEIFER ANDREA, RAVETCH JEFFREY V and EFFIMUNE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | Canada | 5 | |
#6 | China | 4 | |
#7 | Republic of Korea | 3 | |
#8 | Hong Kong | 2 | |
#9 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kisand Kai | 41 |
#2 | Macagno Annalisa | 41 |
#3 | Hayday Adrian | 35 |
#4 | Krohn Kai | 34 |
#5 | Peterson Part | 21 |
#6 | Woodward Martin | 20 |
#7 | Haque Syeda F Y | 20 |
#8 | Rothe Mike | 19 |
#9 | Onuoha Shimobi | 19 |
#10 | Meyer Steffen | 16 |
Publication | Filing date | Title |
---|---|---|
US2017051053A1 | Nucleic acid molecules encoding monoclonal antibodies specific for IL-22 | |
AU2015282844A1 | Human-derived anti-human IL-20 antibodies and assay for the identification of anti-cytokine antibodies | |
KR20160028465A | Human anti-il-32 antibodies | |
WO2015001047A1 | Method of providing anti-human cytokine antibodies for pharmaceutical use | |
CA2917112A1 | Human anti-ifn-alpha antibodies | |
US2014335098A1 | Method of isolating human antibodies |